American Diabetes Association Invests in UpDoc for AI-Driven Chronic Disease Management
The American Diabetes Association (ADA) has made a strategic investment in UpDoc, a clinical AI company focused on improving chronic disease management, particularly for diabetes. This investment will help accelerate UpDoc’s mission to deploy AI-driven solutions that enhance patient care and bridge gaps in chronic disease management caused by clinician shortages and traditional care models.
Strategic investment backs UpDoc’s clinical AI platform, deploying patient-facing AI agents to transform chronic disease care at scale ARLINGTON, Va., June 2, 2026 /PRNewswire/ — Today, the American Diabetes Association® (ADA) announced a strategic investment in UpDoc, an…
